
1. j med chem. 2011 jan 13;54(1):222-32. doi: 10.1021/jm1011462. epub 2010 dec 3.

novel antiviral c5-substituted pyrimidine acyclic nucleoside phosphonates
selected human thymidylate kinase substrates.

topalis d(1), pradère u, roy v, caillat c, azzouzi a, broggi j, snoeck r, andrei 
g, lin j, eriksson s, alexandre ja, el-amri c, deville-bonne d, meyer p,
balzarini j, agrofoglio la.

author information: 
(1)groupe d'enzymologie moléculaire et fonctionnelle, ur4-upmc, université pierre
et marie curie, sorbonne universités, paris, france.

acyclic nucleoside phosphonates (anps) cornerstone dna virus and
retrovirus therapies. reach target, viral dna polymerase, after
two phosphorylation steps catalyzed cellular kinases. new pyrimidine anps have
been synthesized unsaturated acyclic side chains (prop-2-enyl-, but-2-enyl-,
pent-2-enyl-) different substituents c5 position uracil
nucleobase. several derivatives but-2-enyl- series 9d 9e, (e) but
not (z) configuration, efficient substrates human thymidine
monophosphate (tmp) kinase, uridine monophosphate-cytosine
monophosphate (ump-cmp) kinase, contrast cidofovir. human tmp
kinase successfully crystallized complex phosphorylated
(e)-thymidine-but-2-enyl phosphonate 9e adp. bis-pivaloyloxymethyl (pom) 
esters (e)-9d (e)-9e synthesized shown exert activity 
herpes virus vitro (ic(50) = 3 μm) varicella zoster virus vitro
(ic(50) = 0.19 μm), contrast corresponding inactive (z) derivatives.
thus, antiviral activity correlates ability act as
thymidylate kinase substrates.

doi: 10.1021/jm1011462 
pmid: 21128666  [indexed medline]

